I'm in a similar situation (mPSPC) and been on a different ADT (Firmagon first, now Orgolyx), and it's kept my PSA below 0.01 for 2½ years. I'm using it in combination with Erleada, an androgen-reception inhibitor. Given how well I'm responding, my onco team has started talking about many years, up from the original forecast of 5–7.

With these new treatments, everything's in flux.

Jump to this post